INTRAVESICAL DOXORUBICIN FOR PROPHYLAXIS IN THE MANAGEMENT OF RECURRENT SUPERFICIAL BLADDER-CARCINOMA

被引：30

作者：

GARNICK, MB

SCHADE, D

ISRAEL, M

MAXWELL, B

RICHIE, JP

机构：

[1] DANA FARBER CANC INST,DIV PHARMACOL,BOSTON,MA 02115

[2] HARVARD UNIV,BRIGHAM & WOMEN HOSP,SCH MED,DIV UROL,BOSTON,MA 02115

来源：

关键词：

D O I：

10.1016/S0022-5347(17)50189-5

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：43 / 46

页数：4

共 8 条

[1] A CONTROLLED TRIAL OF SINGLE DOSE INTRAVESICAL ADRIAMYCIN IN SUPERFICIAL BLADDER-TUMORS
ABRAMS, PH
CHOA, RG
GACHES, CGC
ASHKEN, MH
GREEN, NA
[J]. BRITISH JOURNAL OF UROLOGY, 1981, 53 (06): : 585 - 587
[2] SUPERFICIAL BLADDER-CANCER - PROGRESSION AND RECURRENCE
HENEY, NM
AHMED, S
FLANAGAN, MJ
FRABLE, W
CORDER, MP
HAFERMANN, MD
HAWKINS, IR
[J]. JOURNAL OF UROLOGY, 1983, 130 (06) : 1083 - 1086
[3] LIQUID-CHROMATOGRAPHIC ANALYSIS OF ADRIAMYCIN AND METABOLITES IN BIOLOGICAL-FLUIDS
ISRAEL, M
PEGG, WJ
WILKINSON, PM
GARNICK, MB
[J]. JOURNAL OF LIQUID CHROMATOGRAPHY, 1978, 1 (06): : 795 - 809
[4] THE USE OF INTRAVESICAL THIO-TEPA IN THE MANAGEMENT OF NON-INVASIVE CARCINOMA OF THE BLADDER
KOONTZ, WW
PROUT, GR
SMITH, W
FRABLE, WJ
MINNIS, JE
[J]. JOURNAL OF UROLOGY, 1981, 125 (03) : 307 - 312
[5] PROUT GR, 1982, CANCER MED, P1896
[6] SCHULMAN CC, 1981, MAY ANN M AM UR ASS
[7] THE MANAGEMENT OF SUPERFICIAL BLADDER-CANCER
SOLOWAY, MS
[J]. CANCER, 1980, 45 (07) : 1856 - 1865
[8] THE ANTICANCER AGENT ADRIAMYCIN CAN BE ACTIVELY CYTO-TOXIC WITHOUT ENTERING CELLS
TRITTON, TR
YEE, G
[J]. SCIENCE, 1982, 217 (4556) : 248 - 250